
NanoGhost is an Israeli biopharmaceutical company developing a targeted drug delivery platform based on nanovesicles reconstructed from the cell membranes of allogeneic mesenchymal stem cells (MSCs). Originating from research at the Technion – Israel Institute of Technology, these non-living "NanoGhosts" retain the natural tropism of stem cells to home in on inflamed and malignant tissues while avoiding immune rejection. Capable of...
nano-ghost.com
Yonatan Malca
Co-Founder and Chief Executive Officer
Prof. Marcelle Machluf
Co-Founder and Chief Scientific Officer